Travere Therapeutics, Inc. (TVTX)
65.22
-0.49
(-0.75%)
USD |
NASDAQ |
Aug 24, 16:00
65.22
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Price : 65.22 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 64.78 | 66.38 | 64.50 | 65.71 | 1.625M |
| Aug 20, 2026 | 64.82 | 65.54 | 64.02 | 64.46 | 1.067M |
| Aug 19, 2026 | 65.00 | 66.19 | 63.34 | 65.96 | 1.522M |
| Aug 18, 2026 | 62.87 | 64.00 | 62.50 | 63.90 | 884907.0 |
| Aug 17, 2026 | 62.15 | 64.38 | 61.62 | 63.53 | 1.566M |
| Aug 14, 2026 | 60.76 | 62.48 | 60.47 | 62.14 | 1.191M |
| Aug 13, 2026 | 63.33 | 63.33 | 61.06 | 61.43 | 1.285M |
| Aug 12, 2026 | 61.34 | 62.32 | 60.40 | 62.16 | 1.041M |
| Aug 11, 2026 | 60.75 | 61.97 | 60.20 | 60.21 | 1.283M |
| Aug 10, 2026 | 60.56 | 62.57 | 60.56 | 60.89 | 1.765M |
| Aug 07, 2026 | 63.53 | 63.71 | 60.67 | 61.32 | 1.227M |
| Aug 06, 2026 | 63.69 | 65.45 | 62.10 | 62.45 | 2.867M |
| Aug 05, 2026 | 62.00 | 66.24 | 61.00 | 62.76 | 6.309M |
| Aug 04, 2026 | 54.93 | 56.67 | 54.22 | 56.02 | 2.464M |
| Aug 03, 2026 | 54.82 | 56.00 | 53.42 | 54.98 | 1.907M |
| Jul 31, 2026 | 57.29 | 57.55 | 55.30 | 55.89 | 1.715M |
| Jul 30, 2026 | 56.39 | 57.84 | 55.56 | 57.28 | 1.015M |
| Jul 29, 2026 | 56.49 | 57.67 | 54.59 | 55.56 | 1.158M |
| Jul 28, 2026 | 56.92 | 57.30 | 55.07 | 55.91 | 1.118M |
| Jul 27, 2026 | 57.95 | 59.09 | 56.67 | 56.68 | 1.663M |
| Jul 24, 2026 | 56.74 | 57.62 | 56.26 | 57.36 | 1.229M |
| Jul 23, 2026 | 54.80 | 60.00 | 54.32 | 56.68 | 1.569M |
| Jul 22, 2026 | 55.29 | 56.44 | 55.29 | 56.26 | 920964.0 |
| Jul 21, 2026 | 55.47 | 56.87 | 55.01 | 56.58 | 1.011M |
| Jul 20, 2026 | 56.55 | 58.10 | 55.26 | 55.47 | 765573.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 264.49 |
| Insmed, Inc. | 124.03 |
| United Therapeutics Corp. | 513.04 |
| Krystal Biotech, Inc. | 341.78 |
| Relay Therapeutics, Inc. | 19.76 |
Price Related Metrics
| PS Ratio | 10.43 |
| Price to Book Value | 250.47 |
| Price to Free Cash Flow | 400.52 |
| Earnings Yield | -1.17% |
| Market Cap | 6.142B |